U.S. Sex Reassignment Surgery Market Size, Share & Trends Analysis Report By Gender Transition (Male To Female, Female To Male), And Segment Forecasts, 2020 - 2027

Report Overview

The U.S. sex reassignment surgery market size was valued at USD 267.0 million in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 14.4% from 2020 to 2027. The rising incidences of gender dysphoria and the increasing number of people deciding for gender confirmation surgeries are expected to boost market growth over the forecast period. Sex reassignment surgeries are performed by a multispecialty staff that usually involves board-certified or licensed plastic surgeons. The objective of surgical procedure is to give transgender individuals the functional abilities and physical appearance of the gender they align their emotional and psychological identity with. It includes procedures such as facial feminization surgery, transfeminine bottom surgery, transfeminine top surgery, transmasculine top surgery, facial masculinization surgery, and transmasculine bottom surgery.

According to the 2019 Plastic Surgery Statistics by the American Society of Plastic Surgeons, around 11,000 gender confirmation or sex reassignment surgeries were performed in the U.S., which was around 10% to 15% higher than the previous year. The increasing number of sex reassignment surgeries in the U.S. will propel the growth of the market during the forecast period.

Transgender people going through sex reassignment or gender confirmation surgery are described as transsexual. Usually, the surgery is done on people with gender dysphoria, and patients experiencing gender dysphoria usually go through unhappiness, anxiety, and depression of not being recognized or accepted by society and having sexual characteristics that they are not comfortable with. Increasing the number of sex reassignment surgeries is among the major factors driving the sex reassignment surgery market.

Improving reimbursement scenario is also anticipated to positively impact the market growth over the forecast period. Insurance providers like Aetna and Unicare provide insurance for necessary surgical procedures, such as salpingo-oophorectomy, hysterectomy, orchiectomy, or ovariectomy.

Gender Transition Insights

Based on gender transition, the market is segmented into male to female and female to male. The female to male segment dominated the market in 2019 and accounted for 55.2% share of the overall revenue. This is attributed to the increasing number of women opting for sex-change surgeries.

Even though most people in the female to male category opt for other procedures, such as chest contouring, bilateral mastectomy (breast removal), and hysterectomy, the number of people opting for sex reassignment surgery is increasing. This is anticipated to maintain the lead of the segment over the forecast period.

Key Companies & Market Share Insights

The ongoing COVID-19 pandemic has forced people worldwide to stay indoors or in self-isolation. This has led to a decrease in the number of sex reassignment surgeries. Everyone is going through an exceptionally stressful time all around the globe. As with many plastic surgeons, most of the surgeries are on hold as they are on the list of the so-called "elective" surgical procedures or surgeries, which include gender-affirming surgeries for patients suffering from gender dysphoria.

Sex reassignment surgeries (SRS) or gender-affirming surgeries are life-altering surgical practices that give transgender individuals the functional abilities and physical appearance of the sexual characteristics of the gender they know themselves to be. The growing acceptance of the transgender population and the rising number of reconstructive surgeries are expected to increase the demand for sex reassignment surgeries during the forecast period. Some prominent players in the U.S. sex reassignment surgery market include:

• Mount Sinai

• Transgender Surgery Institute of Southern California

• Cedars Sinai

• Moein Surgical Arts

• Boston Medical Center

• Cleveland Clinic

• CNY Cosmetic & Reconstructive Surgery

• Plastic Surgery Group Rochester

U.S. Sex Reassignment Surgery Market Report Scope

Segments Covered in the Report

This report forecasts the revenue growth at the country level and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2016 to 2027. For this study, Grand View Research has segmented the U.S. sex reassignment surgery market report based on gender transition:

• Gender Transition Outlook (Revenue, USD Million, 2016 - 2027)

  • Male to Female

  • Female to Male